… medicines” The potential of this new technology for RNA therapeutics is immense, says Bart Klein, who was at the … Bart Klein was at the forefront of ProQR's Axiomer® RNA editing technology development. This platform technology … Biology/Molecular Biology. What is Klein’s connection to RNA therapeutics? “At the end of the 80s, I wrote my master’s …
ProQR's leadership is a strong team with proven track record. Find out who is on our management team, board of directors and scientific advisory board.
At ProQR science is literally at the heart of what we do. Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments.
… Always excited about RNA therapies He is one of the founders of ProQR, but even … as they say. Gerard Platenburg What made you pursue RNAtherapy as a potential treatment for these diseases? “Well, …
… Conference (TIDES Europe) 2022 to highlight our Axiomer® RNA-editing platform technology. This month several ProQRians … here: Axiomer technology - RNA base editing What is RNAtherapy? TIDES Europe 2022 Conference …
… study which aimed to explore whether the investigational RNAtherapy sepofarsen was effective and safe for individuals … more from the ongoing analyses and as they work to advance RNA therapies to potentially help children, adults, and …